Pharmabiz18h
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease: Tokyo Friday, February 21, 2025, 10:00 Hr ...
Pharmabiz12h
Recce Pharma announces positive clinical data from phase II trial of RECCE 327 gel in acute bacterial skin & skin structure infections
Recce Pharma announces positive clinical data from phase II trial of RECCE 327 gel in acute bacterial skin & skin structure infections: Sydney Friday, February 21, 2025, 16:00 Hrs ...
Pharmabiz14h
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution: New York Friday, February 21, 2025, 14:00 Hrs [IST] Aidoc, a global l ...
Pharmabiz11h
The 10th Edition of RaceFor7 to flag off in 21 cities across India simultaneously
The 10th Edition of RaceFor7 to flag off in 21 cities across India simultaneously: Our Bureau, Mumbai Friday, February 21, 2025, 17:30 Hrs [IST] The Organization for Rare Diseases ...
Pharmabiz20h
DGFT introduces mandatory online submissions & digital payments for enforcement & adjudication proceedings
DGFT introduces mandatory online submissions & digital payments for enforcement & adjudication proceedings: Shardul Nautiyal, Mumbai Friday, February 21, 2025, 08:00 Hrs [IST] In ...
Pharmabiz10h
Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial
Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...
Pharmabiz13h
Ono Pharmaceutical’s vimseltinib to treat tenosynovial giant cell tumour gets US FDA approval
Ono Pharmaceutical’s vimseltinib to treat tenosynovial giant cell tumour gets US FDA approval: Osaka Friday, February 21, 2025, 15:00 Hrs [IST] Ono Pharmaceutical, one of the la ...
Pharmabiz15h
Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist
Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...
Pharmabiz11h
Illumina unveils first-of-its-kind spatial transcriptomics technology
Illumina unveils first-of-its-kind spatial transcriptomics technology: San Diego Friday, February 21, 2025, 17:00 Hrs [IST] Illumina, Inc. announced a new spatial technology progr ...
Pharmabiz19h
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...
Pharmabiz20h
Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma
Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma: Nandita Vijayasimha, Bengaluru Friday, February 21, 2025, 08:00 Hrs [IST] The future ...
Pharmabiz20h
TN DCA tightens noose on violators of drug laws as 221 prosecutions were issued in 10 months
TN DCA tightens noose on violators of drug laws as 221 prosecutions were issued in 10 months: Peethaambaran Kunnathoor, Chennai Friday, February 21, 2025, 08:00 Hrs [IST] The drug ...